Target intelligence / Profile preview

Solute carrier family 16 member 14 (SLC16A14)

Target
SLC16A14
Molecular classification
Transporter, Solute carrier family, Monocarboxylate transporter family (orphan type)
01

Overview

Solute carrier family 16 member 14 (SLC16A14), also known as monocarboxylate transporter 14 (MCT14), is an orphan member of the large SLC16 transporter family that typically includes monocarboxylate transporters responsible for the transmembrane movement of substrates such as lactate, pyruvate, ketone bodies, and certain amino acids[2][4][3]. MCT14 has a unique expression pattern, with high mRNA levels in kidney and detectable expression in brain, testis, uterus, and liver. In the kidney, it localizes to the luminal membrane of the thick ascending limb of the loop of Henle and is highly responsive to dietary phosphate levels[2][4]. MCT14 is phylogenetically closest to the aromatic amino acid and thyroid hormone transporters MCT8 (SLC16A2) and MCT10 (SLC16A10), but its endogenous substrate remains unidentified—it does not appear to mediate classical monocarboxylates or thyroid hormones, and evidence for amino acid transport is currently inconclusive[2][4]. The specific physiological function, substrates, and clinical relevance of SLC16A14 remain unclear, though it is presumed to have a role in neuronal amino acid transport, renal nutrient sensing, or related biochemical processes[2][4].

Other names
Monocarboxylate transporter 14MCT14FLJ30794monocarboxylic acid transporter 14solute carrier family 16 (monocarboxylic acid transporters), member 14
02

Mechanism of action

Not established; substrate and drug interactions undetermined due to orphan transporter status

03

Biological functions

Potential transporter of amino acids or related moleculeshypothesized involvement in nutrient sensingneuronal amino acid homeostasiskidney phosphate response
04

Disease associations

Other (no direct evidence for classic roles like cancer, inflammation, neurodegeneration as for other MCT family members)putative link to renal function and metabolic regulation
05

Safety considerations

None reported due to uncharacterized physiological and pharmacological roles
06

Interacting drugs

None known
07

Biomarkers

None currently validated

Beyond the preview

Go deeper on Solute carrier family 16 member 14 (SLC16A14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 16 member 14 (SLC16A14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call